RELX Results Presentation Deck

Scientific, Technical & Medical Underlying growth +1% +1% Revenue 2020 Adjusted operating profit 2020 +3% 2021 +3% 2021 Improved underlying revenue growth driven by further development of datasets and analytics Strong growth in primary research articles published; market share gains in both subscription and open access payment models Databases & Tools and Electronic Reference growth driven by content development, enhanced functionality. Continued strong growth in medical education and clinical solutions 2022 full year outlook: Based on the improved performance in 2021, we expect underlying revenue growth to remain above historical trends, with underlying adjusted operating profit growth slightly exceeding underlying revenue growth & RELX 8

View entire presentation